Merck & Co., Inc., is awaiting a court decision on its motion to dismiss a derivation action captioned Rose v. Hassan, according to the Company’s August 8, 2011, Form 10-Q filing with the U.S. Securities and Exchange Commission for the…
Vornado Realty Trust disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that a lawsuit filed by Stop & Shop is still onding.
On January 8, 2003, Stop & Shop filed a complaint…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the Texas Supreme Court has granted Merck s petition for review and scheduled oral argument for January 20,…
During the first nine months of 2009, Merck & Co. Inc. spent approximately US$190 million in the aggregate in legal defense costs worldwide, including US$65 million in the third quarter of 2009.
The legal expenses were related to (i) the Vioxx…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with U.S. Attorney s Office for the District of Massachusetts.
In March 2009, Merck received a…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that in the MDL proceeding of the Vioxx dispute, the trial of the Louisiana Attorney General case is scheduled…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it continues to respond to the subpoena sent by the State of California Attorney General in connection with…
Loews Corp. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the antitrust dispute captioned In re Insurance Brokerage Antitrust Litigation, Civil No. 04-5184 (FSH) is still pending at a court…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on September 8, 2009, plaintiff filed a second motion for rehearing en banc regarding the Texas state court…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice regarding a probe centered on its Vioxx product activities.
The…